AARABI, B., M. TAGHIPOUR, A. HAGHNEGAHDAR, M. FAROKHI und L. MOBLEY (2000).
"Prognostic factors in the occurrence of posttraumatic epilepsy after penetrating head injury suffered during military service." Neurosurg Focus 8(1).
ADAMEC, R. E. (1990). "Amygdala kindling and anxiety in the rat." Neuroreport 1(3-4): 255-258.
ANDRE, V., C. DUBE, J. FRANCOIS, C. LEROY, M. A. RIGOULOT, C. ROCH, I. J. NAMER und A.
NEHLIG (2007). "Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model." Epilepsia 5: 41-47.
ANDRE, V., A. FERRANDON, C. MARESCAUX und A. NEHLIG (2001). "Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy." Epilepsy Res 47(1-2): 99-117.
ARMSTRONG, C., R. J. MORGAN und I. SOLTESZ (2009). "Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis." Epilepsia 50(7): 1657-1669.
AUVIN, S., N. PORTA, A. NEHLIG, C. LECOINTE, L. VALLEE und R. BORDET (2009). "Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability."
Epilepsy Res 86(2-3): 124-130.
BABB, T. L., J. PEREIRA-LEITE, G. W. MATHERN und J. K. PRETORIUS (1995). "Kainic acid induced hippocampal seizures in rats: comparisons of acute and chronic seizures using intrahippocampal versus systemic injections." Ital J Neurol Sci 16(1-2): 39-44.
BARMASHENKO, G., S. HEFFT, A. AERTSEN, T. KIRSCHSTEIN und R. KOHLING (2011). "Positive shifts of the GABAA receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus." Epilepsia 52(9): 1570-1578.
BEN-ARI, Y. (1985). "Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy." Neuroscience 14(2): 375-403.
BEN-ARI, Y., E. CHERUBINI, R. CORRADETTI und J. L. GAIARSA (1989). "Giant synaptic potentials in immature rat CA3 hippocampal neurones." J Physiol 416: 303-325.
BEN-ARI, Y. und R. COSSART (2000). "Kainate, a double agent that generates seizures: two decades of progress." Trends Neurosci 23(11): 580-587.
BEN-ARI, Y. und G. L. HOLMES (2005). "The multiple facets of gamma-aminobutyric acid dysfunction in epilepsy." Curr Opin Neurol 18(2): 141-145.
BETHMANN, K., C. BRANDT und W. LÖSCHER (2007). "Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy." Epilepsia 48(4): 816-826.
BLOMS-FUNKE, P., M. MADEJA, U. MUSSHOFF und E. J. SPECKMANN (1996). "Effects of pentylenetetrazol on GABA receptors expressed in oocytes of Xenopus laevis: extra- and intracellular sites of action." Neurosci Lett 205(2): 115-118.
BOLANOS, A. R., M. SARKISIAN, Y. YANG, A. HORI, S. L. HELMERS, M. MIKATI, P. TANDON, C.
E. STAFSTROM und G. L. HOLMES (1998). "Comparison of valproate and phenobarbital treatment after status epilepticus in rats." Neurology 51(1): 41-48.
BOLDING, K. und J. W. RUDY (2006). "Place learning in the Morris water task: making the memory stick." Learn Mem 13(3): 278-286.
BOLKVADZE, T. und A. PITKÄNEN (2011). "Development of Post-Traumatic Epilepsy after Controlled Cortical Impact and Lateral Fluid-Percussion Induced Brain Injury in the Mouse." J Neurotrauma 24: 24.
BRAGIN, A., A. AZIZYAN, J. ALMAJANO, C. L. WILSON und J. ENGEL, JR. (2005). "Analysis of chronic seizure onsets after intrahippocampal kainic acid injection in freely moving rats."
Epilepsia 46(10): 1592-1598.
BRAGIN, A., J. ENGEL, JR., C. L. WILSON, E. VIZENTIN und G. W. MATHERN (1999).
"Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection." Epilepsia 40(9): 1210-1221.
BRAGIN, A., C. L. WILSON, J. ALMAJANO, I. MODY und J. ENGEL, JR. (2004). "High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis." Epilepsia 45(9):
1017-1023.
134
BRAGIN, A., C. L. WILSON und J. ENGEL, JR. (2007). "Voltage depth profiles of high-frequency oscillations after kainic acid-induced status epilepticus." Epilepsia 5: 35-40.
BRANDT, C., A. M. GASTENS, M. SUN, M. HAUSKNECHT und W. LÖSCHER (2006). "Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats." Neuropharmacology 51(4): 789-804.
BRANDT, C., M. GLIEN, A. M. GASTENS, M. FEDROWITZ, K. BETHMANN, H. A. VOLK, H.
POTSCHKA und W. LÖSCHER (2007). "Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats." Neuropharmacology 53(2): 207-221.
BRANDT, C., M. GLIEN, H. POTSCHKA, H. VOLK und W. LOSCHER (2003). "Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats." Epilepsy Res 55(1-2): 83-103.
BRANDT, C., M. NOZADZE, N. HEUCHERT, M. RATTKA und W. LÖSCHER (2010). "Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy." J Neurosci 30(25): 8602-8612.
BRANDT, C., H. A. VOLK und W. LÖSCHER (2004). "Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus."
Epilepsia 45(12): 1488-1497.
BUMANGLAG, A. V. und R. S. SLOVITER (2008). "Minimal latency to hippocampal epileptogenesis and clinical epilepsy after perforant pathway stimulation-induced status epilepticus in awake rats." J Comp Neurol 510(6): 561-580.
CAVALHEIRO, E. A., D. A. RICHE und G. LE GAL LA SALLE (1982). "Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures." Electroencephalogr Clin Neurophysiol 53(6): 581-589.
CHANG, B. S. und D. H. LOWENSTEIN (2003). "Epilepsy." N Engl J Med 349(13): 1257-1266.
CHEN, K., A. NEU, A. L. HOWARD, C. FOLDY, J. ECHEGOYEN, L. HILGENBERG, M. SMITH, K.
MACKIE und I. SOLTESZ (2007). "Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures." J Neurosci 27(1): 46-58.
CHROSCINSKA-KRAWCZYK, M., M. JARGIELLO-BASZAK, M. WALEK, B. TYLUS und S. J.
CZUCZWAR (2011). "Caffeine and the anticonvulsant potency of antiepileptic drugs:
experimental and clinical data." Pharmacol Rep 63(1): 12-18.
COHEN, I., V. NAVARRO, S. CLEMENCEAU, M. BAULAC und R. MILES (2002). "On the origin of interictal activity in human temporal lobe epilepsy in vitro." Science 298(5597): 1418-1421.
COPER, H. und W. M. HERRMANN (1988). "Psychostimulants, analeptics, nootropics: an attempt to differentiate and assess drugs designed for the treatment of impaired brain functions."
Pharmacopsychiatry 21(5): 211-217.
COULTER, D. A. (2001). "Epilepsy-associated plasticity in gamma-aminobutyric acid receptor expression, function, and inhibitory synaptic properties." Int Rev Neurobiol 45: 237-252.
CURIA, G., D. LONGO, G. BIAGINI, R. S. JONES und M. AVOLI (2008). "The pilocarpine model of temporal lobe epilepsy." J Neurosci Methods 172(2): 143-157.
D'HOOGE, R. und P. P. DE DEYN (2001). "Applications of the Morris water maze in the study of learning and memory." Brain Res Brain Res Rev 36(1): 60-90.
DALBY, N. O. und I. MODY (2001). "The process of epileptogenesis: a pathophysiological approach."
Curr Opin Neurol 14(2): 187-192.
DELANTY, N., C. J. VAUGHAN und J. A. FRENCH (1998). "Medical causes of seizures." Lancet 352(9125): 383-390.
DELORENZO, R., MORRIS TA, BLAIR RE, WALLACE M und R. B (2002). "Topiramate is both neuroprotective and antiepileptogenic in the pilocarpine model of status epilepticus." Epilepsia 43(Suppl 7): 15.
DETOUR, J., H. SCHROEDER, D. DESOR und A. NEHLIG (2005). "A 5-month period of epilepsy impairs spatial memory, decreases anxiety, but spares object recognition in the lithium-pilocarpine model in adult rats." Epilepsia 46(4): 499-508.
DICHTER, M. A. (2009 ). "Emerging concepts in the pathogenesis of epilepsy and epileptogenesis."
Arch Neurol 66(4): 443-447.
DUDEK, F. E., W. A. POULIOT, C. A. ROSSI und K. J. STALEY (2010). "The effect of the cannabinoid-receptor antagonist, SR141716, on the early stage of kainate-induced epileptogenesis in the adult rat." Epilepsia 3: 126-130.
135
DZHALA, V. I., A. C. BRUMBACK und K. J. STALEY (2008). "Bumetanide enhances phenobarbital efficacy in a neonatal seizure model." Ann Neurol 63(2): 222-235.
DZHALA, V. I., D. M. TALOS, D. A. SDRULLA, A. C. BRUMBACK, G. C. MATHEWS, T. A. BENKE, E.
DELPIRE, F. E. JENSEN und K. J. STALEY (2005). "NKCC1 transporter facilitates seizures in the developing brain." Nat Med 11(11): 1205-1213.
ECHEGOYEN, J., C. ARMSTRONG, R. J. MORGAN und I. SOLTESZ (2009). "Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model." Epilepsy Res 85(1): 123-127.
EFTEKHAR, B., M. A. SAHRAIAN, B. NOURALISHAHI, A. KHAJI, Z. VAHABI, M. GHODSI, H.
ARAGHIZADEH, M. R. SOROUSH, S. K. ESMAEILI und M. MASOUMI (2009). "Prognostic factors in the persistence of posttraumatic epilepsy after penetrating head injuries sustained in war." J Neurosurg 110(2): 319-326.
ENGEL, J., JR. (1996 a). "Introduction to temporal lobe epilepsy." Epilepsy Res 26(1): 141-150.
ENGEL, J., JR. (1996 b). "Excitation and inhibition in epilepsy." Can J Neurol Sci 23(3): 167-174.
ENGLANDER, J., T. BUSHNIK, T. T. DUONG, D. X. CIFU, R. ZAFONTE, J. WRIGHT, R. HUGHES und W. BERGMAN (2003). "Analyzing risk factors for late posttraumatic seizures: a prospective, multicenter investigation." Arch Phys Med Rehabil 84(3): 365-373.
ESPLIN, D. W. und D. M. WOODBURY (1956). "The fate and excretion of C14-labeled pentylenetetrazol in the rat, with comments on analytical methods for pentylenetetrazol." J Pharmacol Exp Ther 118(2): 129-138.
FERNANDEZ, F., W. MORISHITA, E. ZUNIGA, J. NGUYEN, M. BLANK, R. C. MALENKA und C. C.
GARNER (2007). "Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome." Nat Neurosci 10(4): 411-413.
FINK, M. (1972). "CNS effects of convulsive therapy: significance for a theory of depressive psychosis." Proc Annu Meet Am Psychopathol Assoc 60: 93-115.
FINK, M. (1984). "Meduna and the origins of convulsive therapy." Am J Psychiatry 141(9): 1034-1041.
FINN, D. A. und K. W. GEE (1994). "The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid." J Pharmacol Exp Ther 271(1): 164-170.
FISHER, R. S., W. VAN EMDE BOAS, W. BLUME, C. ELGER, P. GENTON, P. LEE und J. ENGEL, JR. (2005). "Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)." Epilepsia 46(4): 470-472.
FOLDVARY, N., W. E. BINGAMAN und E. WYLLIE (2001). "Surgical treatment of epilepsy." Neurol Clin 19(2): 491-515.
FRANCOIS, J., K. GERME, A. FERRANDON, E. KONING und A. NEHLIG (2011). "Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy."
Neuropharmacology 61(1-2): 313-328.
FRENCH, J. A., P. D. WILLIAMSON, V. M. THADANI, T. M. DARCEY, R. H. MATTSON, S. S.
SPENCER und D. D. SPENCER (1993). "Characteristics of medial temporal lobe epilepsy: I.
Results of history and physical examination." Ann Neurol 34(6): 774-780.
FURTADO, M. A., O. W. CASTRO, F. DEL VECCHIO, J. A. DE OLIVEIRA und N. GARCIA-CAIRASCO (2011). "Study of spontaneous recurrent seizures and morphological alterations after status epilepticus induced by intrahippocampal injection of pilocarpine." Epilepsy Behav 20(2): 257-266.
GARCIA-MORALES, I., P. DE LA PENA MAYOR und A. M. KANNER (2008). "Psychiatric comorbidities in epilepsy: identification and treatment." Neurologist 14(6 Suppl 1): S15-25.
GASTENS, A. M., C. BRANDT, J. P. BANKSTAHL und W. LÖSCHER (2008). "Predictors of pharmacoresistant epilepsy: pharmacoresistant rats differ from pharmacoresponsive rats in behavioral and cognitive abnormalities associated with experimentally induced epilepsy."
Epilepsia 49(10): 1759-1776.
GERNERT, M. und W. LÖSCHER (2001). "Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats." Eur J Pharmacol 432(1): 35-41.
GLIEN, M., C. BRANDT, H. POTSCHKA und W. LÖSCHER (2002). "Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy." Epilepsia 43(4): 350-357.
GLIEN, M., C. BRANDT, H. POTSCHKA, H. VOIGT, U. EBERT und W. LÖSCHER (2001). "Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy." Epilepsy Res 46(2): 111-119.
136
GLYKYS, J., V. I. DZHALA, K. V. KUCHIBHOTLA, G. FENG, T. KUNER, G. AUGUSTINE, B. J.
BACSKAI und K. J. STALEY (2009). "Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures." Neuron 63(5): 657-672.
GODDARD, G. V., D. C. MCINTYRE und C. K. LEECH (1969). "A permanent change in brain function resulting from daily electrical stimulation." Exp Neurol 25(3): 295-330.
GOFFIN, K., J. NISSINEN, K. VAN LAERE und A. PITKANEN (2007). "Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat." Exp Neurol 205(2):
501-505.
GOLARAI, G., J. E. CAVAZOS und T. P. SUTULA (1992). "Activation of the dentate gyrus by pentylenetetrazol evoked seizures induces mossy fiber synaptic reorganization." Brain Res 593(2): 257-264.
GREEN, A. R. (1986). "Changes in gamma-aminobutyric acid biochemistry and seizure threshold."
Ann N Y Acad Sci 462: 105-119.
GRÖTICKE, I., K. HOFFMANN und W. LÖSCHER (2008). "Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate." Exp Neurol 213(1):
71-83.
HALONEN, T., T. KOTTI, J. TUUNANEN, A. TOPPINEN, R. MIETTINEN und P. J. RIEKKINEN (1995). "Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage." Brain Res 693(1-2): 217-224.
HAMILTON, S. E., M. D. LOOSE, M. QI, A. I. LEVEY, B. HILLE, G. S. MCKNIGHT, R. L. IDZERDA und N. M. NATHANSON (1997). "Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice." Proc Natl Acad Sci U S A 94(24): 13311-13316.
HANDELMANN, G. E. und D. S. OLTON (1981). "Spatial memory following damage to hippocampal CA3 pyramidal cells with kainic acid: impairment and recovery with preoperative training."
Brain Res 217(1): 41-58.
HELFER, V., C. DERANSART, C. MARESCAUX und A. DEPAULIS (1996). "Amygdala kindling in the rat: anxiogenic-like consequences." Neuroscience 73(4): 971-978.
HERMANN, B., M. SEIDENBERG und J. JONES (2008). "The neurobehavioural comorbidities of epilepsy: can a natural history be developed?" Lancet Neurol 7(2): 151-160.
HOPPE, C., C. E. ELGER und C. HELMSTAEDTER (2007). "Long-term memory impairment in patients with focal epilepsy." Epilepsia 9: 26-29.
HUANG, R. Q., C. L. BELL-HORNER, M. I. DIBAS, D. F. COVEY, J. A. DREWE und G. H. DILLON (2001). "Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action." J Pharmacol Exp Ther 298(3): 986-995.
JACOBS, M. P., G. G. LEBLANC, A. BROOKS-KAYAL, F. E. JENSEN, D. H. LOWENSTEIN, J. L.
NOEBELS, D. D. SPENCER und J. W. SWANN (2009). "Curing epilepsy: progress and future directions." Epilepsy Behav 14(3): 438-445.
JENSEN, F. E. (2011). "Epilepsy as a spectrum disorder: Implications from novel clinical and basic neuroscience." Epilepsia 1: 1-6.
JESSBERGER, S., K. NAKASHIMA, G. D. CLEMENSON, JR., E. MEJIA, E. MATHEWS, K. URE, S.
OGAWA, C. M. SINTON, F. H. GAGE und J. HSIEH (2007). "Epigenetic modulation of seizure-induced neurogenesis and cognitive decline." J Neurosci 27(22): 5967-5975.
JONES, R., H. RICKARDS und A. E. CAVANNA (2010). "The prevalence of psychiatric disorders in epilepsy: a critical review of the evidence." Funct Neurol 25(4): 191-194.
JUNG, K. H., K. CHU, S. T. LEE, J. KIM, D. I. SINN, J. M. KIM, D. K. PARK, J. J. LEE, S. U. KIM, M.
KIM, S. K. LEE und J. K. ROH (2006). "Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus." Neurobiol Dis 23(2): 237-246.
JUNG, M. E., H. LAL und M. B. GATCH (2002). "The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments." Neurosci Biobehav Rev 26(4):
429-439.
KÄLVIÄINEN, R., T. SALMENPERA, K. PARTANEN, P. VAINIO, P. RIEKKINEN und A. PITKÄNEN (1998). "Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy."
Neurology 50(5): 1377-1382.
KANNER, A. M. (2011). "Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity." Epilepsy Curr 11(3): 90-91.
137
KÖHLING, R. (2002). "Neuroscience. GABA becomes exciting." Science 298(5597): 1350-1351.
KÜCKER, S., K. TÖLLNER, M. PIECHOTTA und M. GERNERT (2010). "Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity." Neurobiol Dis 37(3): 661-672.
KWAN, P., A. ARZIMANOGLOU, A. T. BERG, M. J. BRODIE, W. ALLEN HAUSER, G. MATHERN, S.
L. MOSHE, E. PERUCCA, S. WIEBE und J. FRENCH (2010). "Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies." Epilepsia 51(6): 1069-1077.
LANGER, M., C. BRANDT, C. ZELLINGER und W. LÖSCHER (2011). "Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats." Neuropharmacology 61(5-6): 1033-1047.
LEITE, J. P., Z. A. BORTOLOTTO und E. A. CAVALHEIRO (1990 a). "Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy." Neurosci Biobehav Rev 14(4):
511-517.
LEITE, J. P., E. M. NAKAMURA, T. LEMOS, J. MASUR und E. A. CAVALHEIRO (1990 b). "Learning impairment in chronic epileptic rats following pilocarpine-induced status epilepticus." Braz J Med Biol Res 23(8): 681-683.
LEROY, C., P. POISBEAU, A. F. KELLER und A. NEHLIG (2004). "Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy." J Physiol 557(Pt 2): 473-487.
LHATOO, S. D., J. W. SANDER und D. FISH (2001). "Temporal lobe epilepsy following febrile seizures: unusually prolonged latent periods." Eur Neurol 46(3): 165-166.
LI, X., J. ZHOU, Z. CHEN, S. CHEN, F. ZHU und L. ZHOU (2008). "Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE)." Brain Res 24:
141-146.
LODGE, D., G. A. JOHNSTON, D. R. CURTIS und J. C. BORNSTEIN (1979). "Kainate neurotoxicity and glutamate inactivation." Neurosci Lett 14(2-3): 343-348.
LÖSCHER, W. (2002). "Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy." Epilepsy Res 50(1-2): 105-123.
LÖSCHER, W. (2007). "The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy." Epilepsia 48(7): 1245-1258.
LÖSCHER, W. (2009). "Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans." Eur J Pharmacol 610(1-3): 1-11.
LÖSCHER, W. (2011). "Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs." Seizure 20(5): 359-368.
LÖSCHER, W. und C. BRANDT (2010 a). "Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research." Pharmacol Rev 62(4): 668-700.
LÖSCHER, W. und C. BRANDT (2010 b). "High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy." Epilepsia 51(1): 89-97.
LÖSCHER, W., M. GERNERT und U. HEINEMANN (2008). "Cell and gene therapies in epilepsy--promising avenues or blind alleys?" Trends Neurosci 31(2): 62-73.
LÖSCHER, W., D. HÖNACK und C. RUNDFELDT (1998). "Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy." J Pharmacol Exp Ther 284(2): 474-479.
LÖSCHER, W. und R. KÖHLING (2010). "Functional, metabolic, and synaptic changes after seizures as potential targets for antiepileptic therapy." Epilepsy Behav 19(2): 105-113.
138
LÖSCHER, W. und D. SCHMIDT (2006). New Horizons in the development of antiepileptic drugs:
Innovative strategies, Epilepsy Res. 2006 Jun;69(3):183-272.
MACDONALD, R. L. und J. L. BARKER (1977). "Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones."
Nature 267(5613): 720-721.
MAJORES, M., J. EILS, O. D. WIESTLER und A. J. BECKER (2004). "Molecular profiling of temporal lobe epilepsy: comparison of data from human tissue samples and animal models." Epilepsy Res 60(2-3): 173-178.
MANI, R., J. POLLARD und M. A. DICHTER (2011). "Human clinical trails in antiepileptogenesis."
Neurosci Lett 497(3): 251-256.
MANN, E. O. und I. MODY (2008). "The multifaceted role of inhibition in epilepsy: seizure-genesis through excessive GABAergic inhibition in autosomal dominant nocturnal frontal lobe epilepsy." Curr Opin Neurol 21(2): 155-160.
MARCHI, N., Q. FAN, C. GHOSH, V. FAZIO, F. BERTOLINI, G. BETTO, A. BATRA, E. CARLTON, I.
NAJM, T. GRANATA und D. JANIGRO (2009). "Antagonism of peripheral inflammation reduces the severity of status epilepticus." Neurobiol Dis 33(2): 171-181.
MARCUCCI, F., M. L. AIROLDI, E. MUSSINI und S. GARATTINI (1971). "Brain levels of metrazol determined with a new gas chromatographic procedure." Eur J Pharmacol 16(2): 219-221.
MARGERISON, J. H. und J. A. CORSELLIS (1966). "Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes." Brain 89(3): 499-530.
MAZARATI, A., D. SHIN und R. SANKAR (2009). "Bumetanide inhibits rapid kindling in neonatal rats."
Epilepsia 50(9): 2117-2122.
MIRSKI, M. A. und J. A. FERRENDELLI (1986). "Anterior thalamic mediation of generalized pentylenetetrazol seizures." Brain Res 399(2): 212-223.
MIRSKI, M. A. und J. A. FERRENDELLI (1987). "Interruption of the connections of the mammillary bodies protects against generalized pentylenetetrazol seizures in guinea pigs." J Neurosci 7(3): 662-670.
MORIMOTO, K., M. FAHNESTOCK und R. J. RACINE (2004). "Kindling and status epilepticus models of epilepsy: rewiring the brain." Prog Neurobiol 73(1): 1-60.
MORRIS, R. (1984). "Developments of a water-maze procedure for studying spatial learning in the rat." J Neurosci Methods 11(1): 47-60.
MUNOZ, C. und S. P. GROSSMAN (1980). "Some behavioral effects of selective neuronal depletion by kainic acid in the dorsal hippocampus of rats." Physiol Behav 25(4): 581-587.
NAGAO, T., A. ALONSO und M. AVOLI (1996). "Epileptiform activity induced by pilocarpine in the rat hippocampal-entorhinal slice preparation." Neuroscience 72(2): 399-408.
NISSINEN, J., T. HALONEN, E. KOIVISTO und A. PITKANEN (2000). "A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat." Epilepsy Res 38(2-3): 177-205.
NISSINEN, J. und A. PITKÄNEN (2007). "Effect of antiepileptic drugs on spontaneous seizures in epileptic rats." Epilepsy Res 73(2): 181-191.
NUTT, D. J., P. J. COWEN und A. R. GREEN (1981). "Studies on the post-ictal rise in seizure threshold." Eur J Pharmacol 71(2-3): 287-295.
OLNEY, J. W., V. RHEE und O. L. HO (1974). "Kainic acid: a powerful neurotoxic analogue of glutamate." Brain Res 77(3): 507-512.
ORLOFF, M. J., H. L. WILLIAMS und C. C. PFEIFFER (1949). "Timed intravenous infusion of metrazol and strychnine for testing anticonvulsant drugs." Proc Soc Exp Biol Med 70(2): 254-257.
PALMA, E., M. AMICI, F. SOBRERO, G. SPINELLI, S. DI ANGELANTONIO, D. RAGOZZINO, A.
MASCIA, C. SCOPPETTA, V. ESPOSITO, R. MILEDI und F. EUSEBI (2006). "Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory." Proc Natl Acad Sci U S A 103(22): 8465-8468.
PATHAK, H. R., F. WEISSINGER, M. TERUNUMA, G. C. CARLSON, F. C. HSU, S. J. MOSS und D.
A. COULTER (2007). "Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy." J Neurosci 27(51): 14012-14022.
PAVLOV, I., N. HUUSKO, M. DREXEL, E. KIRCHMAIR, G. SPERK, A. PITKANEN und M. C.
WALKER (2011). "Progressive loss of phasic, but not tonic, GABA(A) receptor-mediated inhibition in dentate granule cells in a model of post-traumatic epilepsy in rats." Neuroscience 194: 208-219.
139
PAXINOS, G. und C. WATSON, Eds. (2007). The Rat Brain in Stereotactic Coordinates. Amsterdam.
PITKÄNEN, A. (2010). "Therapeutic approaches to epileptogenesis--hope on the horizon." Epilepsia 3:
2-17.
PITKÄNEN, A., T. BOLKVADZE und R. IMMONEN (2011 ). "Anti-epileptogenesis in rodent post-traumatic epilepsy models." Neurosci Lett 497(3): 163-171.
PITKÄNEN, A. und K. LUKASIUK (2011). "Mechanisms of epileptogenesis and potential treatment targets." Lancet Neurol 10(2): 173-186.
PITKÄNEN, A., S. NARKILAHTI, Z. BEZVENYUK, A. HAAPALINNA und J. NISSINEN (2004).
"Atipamezole, an alpha(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats." Epilepsy Res 61(1-3): 119-140.
POLASCHECK, N., M. BANKSTAHL und W. LÖSCHER (2010). "The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy."
Exp Neurol 224(1): 219-233.
POTSCHKA, H. und W. LÖSCHER (2001). "In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats." Epilepsia 42(10): 1231-1240.
PUURUNEN, K., J. JOLKKONEN, J. SIRVIO, A. HAAPALINNA und J. SIVENIUS (2001). "An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats." Neuropharmacology 40(4): 597-606.
QIAN, B., Y. SUN, Z. WU, L. WAN, L. CHEN, S. KONG, B. ZHANG, F. ZHANG, Z. Y. WANG und Y.
WANG (2011). "Epileptiform response of CA1 neurones to convulsant stimulation by cyclothiazide, kainic acid and pentylenetetrazol in anaesthetized rats." Seizure 20(4): 312-319.
RACINE, R. J. (1972). "Modification of seizure activity by electrical stimulation. II. Motor seizure."
Electroencephalogr Clin Neurophysiol 32(3): 281-294.
RAEDT, R., A. VAN DYCKE, D. VAN MELKEBEKE, T. DE SMEDT, P. CLAEYS, T. WYCKHUYS, K.
VONCK, W. WADMAN und P. BOON (2009). "Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat." Acta Neurol Scand 119(5): 293-303.
RAMANJANEYULU, R. und M. K. TICKU (1984). "Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex." Eur J Pharmacol 98(3-4): 337-345.
RAMZAN, I. M. und G. LEVY (1985). "Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions." J Pharmacol Exp Ther 234(3): 624-628.
RIBAN, V., V. BOUILLERET, B. T. PHAM-LÊ, J. M. FRITSCHY, C. MARESCAUX und A. DEPAULIS (2002). "Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy." Neuroscience 112(1): 101-111.
RICE, A. C., C. L. FLOYD, B. G. LYETH, R. J. HAMM und R. J. DELORENZO (1998). "Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits." Epilepsia 39(11): 1148-1157.
RICHTLINIEN DER AMERICAN ASSOCIATION FOR THE TRAUMA SURGERY (2001). "Antiseizure prophylaxis for penetrating brain injury." J Trauma 51(2 Suppl): S41-43.
RIGOULOT, M. A., E. KONING, A. FERRANDON und A. NEHLIG (2004). "Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy." J Pharmacol Exp Ther 308(2): 787-795.
RIGOULOT, M. A., C. LEROY, E. KONING, A. FERRANDON und A. NEHLIG (2003). "Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat." Epilepsia 44(4): 529-535.
SCHACHER, M., R. WINKLER, T. GRUNWALD, G. KRAEMER, M. KURTHEN, V. REED und H.
JOKEIT (2006). "Mesial temporal lobe epilepsy impairs advanced social cognition." Epilepsia 47(12): 2141-2146.
SCHARFMAN, H. E. und N. J. MACLUSKY (2006). "The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female." Epilepsia 47(9): 1423-1440.
SHORR, E. (1940). "A New Technic for Staining Vaginal Smears." Science 91(2361): 321-322.
SHORVON, S. D. (2011). "The etiologic classification of epilepsy." Epilepsia 52(6): 1052-1057.
SILLANPÄÄ, M. und D. SCHMIDT (2006). "Natural history of treated childhood-onset epilepsy:
prospective, long-term population-based study." Brain 129(Pt 3): 617-624.
SILVER, J. M., C. SHIN und J. O. MCNAMARA (1991). "Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy." Ann Neurol 29(4): 356-363.
140
SLOVITER, R. S. (1994). "The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy." Ann Neurol 35(6): 640-654.
SLOVITER, R. S. (2005). "The neurobiology of temporal lobe epilepsy: too much information, not enough knowledge." C R Biol 328(2): 143-153.
SLOVITER, R. S. (2008). "Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts."
SLOVITER, R. S. (2008). "Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts."